Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1.

Abolhasani S, Salehi Khesht AM, Khodakarami A, Masjedi A, Rashidi B, Izadi S, Noukabadi FK, Karpisheh V, Poudeh KT, Jalali P, Salehi Z, Bagherifar R, Hejazian SS, Movassaghpour A, Feizi AAH, Jadidi F

Open source

DOI: 10.1186/s12935-025-03702-4
Published: 2025 Mar 19
Container: Cancer cell international
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12935-025-03702-4,
  title = {Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1.},
  author = {Abolhasani S and Salehi Khesht AM and Khodakarami A and Masjedi A and Rashidi B and Izadi S and Noukabadi FK and Karpisheh V and Poudeh KT and Jalali P and Salehi Z and Bagherifar R and Hejazian SS and Movassaghpour A and Feizi AAH and Jadidi F},
  year = {2025},
  journal = {Cancer cell international},
  doi = {10.1186/s12935-025-03702-4},
  url = {https://doi.org/10.1186/s12935-025-03702-4}
}

RIS

TY  - JOUR
TI  - Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1.
AU  - Abolhasani S
AU  - Salehi Khesht AM
AU  - Khodakarami A
AU  - Masjedi A
AU  - Rashidi B
AU  - Izadi S
AU  - Noukabadi FK
AU  - Karpisheh V
AU  - Poudeh KT
AU  - Jalali P
AU  - Salehi Z
AU  - Bagherifar R
AU  - Hejazian SS
AU  - Movassaghpour A
AU  - Feizi AAH
AU  - Jadidi F
PY  - 2025
JO  - Cancer cell international
DO  - 10.1186/s12935-025-03702-4
UR  - https://doi.org/10.1186/s12935-025-03702-4
ER  -

APA

S, A., AM, S. K., A, K., A, M., B, R., S, I., FK, N., V, K., KT, P., P, J., Z, S., R, B., SS, H., A, M., AAH, F., & F, J. (2025). Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1.. Cancer cell international. https://doi.org/10.1186/s12935-025-03702-4

Source records

pubmed · retrieved 2026-11-10T18:05:03.611Z